Methyl 5-(thiophen-2-yl)isoxazole-3-carboxylate

Catalog No. :
ACHLKR352
CAS No. :
517870-23-4
Molecular Formula :
C9H7NO3S
Molecular Weight :
209.23

IUPAC Name:methyl 5-(thiophen-2-yl)isoxazole-3-carboxylate

Methyl 5-(thiophen-2-yl)isoxazole-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$104.00Login to see priceIn stockIn stock
25g97%$361.00Login to see priceIn stockIn stock
100g97%$1444.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 5-(thiophen-2-yl)isoxazole-3-carboxylate
IUPAC Namemethyl 5-(thiophen-2-yl)isoxazole-3-carboxylate
MDL No.MFCD03778976
Molecular FormulaC9H7NO3S
Molecular Weight209.23
SMILESO=C(C1=NOC(C2=CC=CS2)=C1)OC
InChI KeyHNUBQXDECCWAJW-UHFFFAOYSA-N
Synonym517870-23-4 | methyl 5-(2-thienyl)isoxazole-3-carboxylate | methyl 5-(thiophen-2-yl)isoxazole-3-carboxylate | methyl 5-thiophen-2-yl-1,2-oxazole-3-carboxylate | methyl 5-(thiophen-2-yl)-1,2-oxazole-3-carboxylate | 5-THIOPHEN-2-YL-ISOXAZOLE-3-CARBOXYLIC ACID METHYL
CAS No.517870-23-4
PubChem CID1256578

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACHLKR352 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHLKR352 route product structure diagram
    ACHLKR352517870-23-4 In Stock
Inquiry

2. ACHLKR352 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUXRB496 route compound structure diagram
    ACUXRB4966165-68-0 In Stock
  4. Then
  5. ACHLKR352 route product structure diagram
    ACHLKR352517870-23-4 In Stock
Inquiry

Comments (0)